FDA Announces Recall of Allergy Medication Due to Ranitidine Cross-Contamination Risk

Unique Pharmaceutical Laboratories has voluntarily recalled four lots of Cetirizine Hydrochloride Tablets USP 5 mg after discovering potential cross-contamination with ranitidine, a drug used for heartburn. The FDA notice highlights that this contamination could pose life-threatening risks, especially for individuals with hypersensitivity to ranitidine ingredients, potentially leading to severe allergic reactions including anaphylaxis.